Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous insulin-producing cell transplantation from adipose-derived stem cells in type 1 diabetes
jRCT2063250055Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of TUFF-IPC in diabetes mellitus type 1 (T1D), sponsored by Japan Agency for Medical Research and Development. Started Jan 2026; status: active, not recruiting.
02
Drugs
TUFF-IPC
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on jRCT2063250055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2063250055.